Obesity Trial, Recruiting NCT07703371 Sponsor: JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07703371
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 20 and 60 years of age
  • People who are willing to give their formal consent to participate in the study
  • People who are willing to eat Kodo millet porridge every day for 12 weeks
  • People who do not plan to change their diet or exercise habits during the study period
  • People who are overweight or obese, meaning a body mass index (BMI) of 25 or higher, which can increase the risk of certain health conditions related to metabolism

Who may not be able to join:

  • People with a known allergy to millet or any of the ingredients in the porridge
  • People who are currently taking over-the-counter dietary fibre or probiotic supplements
  • People with a history of long-term digestive or gut conditions, such as inflammatory bowel disease, gastritis, or irritable bowel syndrome
  • Women who are pregnant or currently breastfeeding
  • People who have used antibiotics in the last 3 months
  • People who drink more than 2 alcoholic drinks per day
  • People who have serious ongoing health conditions and are taking medication for them — this includes poorly controlled diabetes, heart or blood vessel disease, kidney disease, neurological or mental health conditions, blood clotting disorders, or cancer (confirm with trial site for the full list of specific medications that may be relevant)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Prerana Shridhar Bhat, MSc, JSS MC,JSS AHER

Phone: +918762399079

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
16 October 2026

Where this trial is recruiting

🇮🇳 India

Primary endpoints

Change in Gut Microbiota Composition and Diversity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov